Autosomal Dominant Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
Phase 3 trial evaluating the effect of statin therapy on disease progression in autosomal dominant polycystic kidney disease completed with …
-
CLINICAL_TRIALS trial_result · 2018-01-10Clinical Trial Update: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency [Phase 3]
Phase 3 clinical trial in autosomal dominant polycystic kidney disease with moderate to severe renal insufficiency has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study [NA]
The Mayo Clinic-sponsored clinical trial evaluating pain in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
A Phase 3 study evaluating the efficacy and safety of tolvaptan in autosomal dominant polycystic kidney disease has completed, with results …
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Tolvaptan Open-label Pilot Efficacy, Tolerability, and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]
Open-label Phase 2 pilot study evaluating tolvaptan for efficacy, tolerability, and safety in autosomal dominant polycystic kidney disease. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]
Phase 2 trial update evaluating short-term renal hemodynamic effects of tolvaptan in autosomal dominant polycystic kidney disease.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease [Phase 2, Phase 3]
This clinical trial update notes completed Phase 2 and Phase 3 studies investigating diet as a potential treatment for Autosomal Dominant Po…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Clinical Implications of DNA Analysis on ADPKD
A completed clinical trial update evaluating the clinical implications of DNA analysis for Autosomal Dominant Polycystic Kidney Disease (ADP…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Effect of the Aquaretic Tolvaptan on Nitric Oxide System [Phase 2]
A Phase 2 trial evaluating tolvaptan's effect on the nitric oxide system in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
A completed Mayo Clinic-backed clinical trial evaluated new quantitative MRI parameters to assess kidney involvement in autosomal dominant p…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: High Water Intake to Slow Progression of Polycystic Kidney Disease [NA]
A completed trial examined whether high water intake could slow the progression of autosomal dominant polycystic kidney disease; results wer…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Bosutinib For Autosomal Dominant Polycystic Kidney Disease [Phase 2]
A Phase 2 trial of bosutinib for autosomal dominant polycystic kidney disease has completed, and results were posted in October 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD) [NA]
A University of Kansas-sponsored trial tested a new diet for autosomal dominant polycystic kidney disease and has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: ADPKD Cohort Study
An Emory University–sponsored cohort study on Autosomal Dominant Polycystic Kidney Disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Everolimus on CKD Progression in ADPKD Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 trial of everolimus for slowing CKD progression in autosomal dominant polycystic kidney disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 1, Phase 2]
A Phase 1/2 pilot trial evaluated rapamycin (sirolimus) for autosomal dominant polycystic kidney disease; the study completed and results we…
-
CLINICAL_TRIALS trial_result · 2015-03-30Clinical Trial Update: Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease [NA]
This clinical trial update reports a randomized trial of Triptolide Woldifii for autosomal dominant polycystic kidney disease, which was ter…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 4]
This clinical trial update reports on the efficacy, safety and tolerability of everolimus in preventing end-stage renal disease in autosomal…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Somatostatin on ADPKD Heart [Phase 2, Phase 3]
Phase 2/3 trial evaluating somatostatin for heart-related outcomes in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Somatostatin on Liver in ADPKD [Phase 2, Phase 3]
A report on the completion of a Phase 2/3 clinical trial evaluating somatostatin for liver involvement in autosomal dominant polycystic kidn…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
An update on a Phase 3 clinical trial evaluating a triptolide-containing formulation for autosomal dominant polycystic kidney disease (ADPKD…
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy [Phase 2, Phase 3]
A clinical trial update summarizing Phase 2/3 results of rapamycin (sirolimus) for autosomal dominant polycystic kidney disease and the use …
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 3]
A Phase 3 trial evaluated sirolimus (Rapamune) for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety [Phase 2]
Phase 2 trial evaluating sirolimus for renal efficacy and safety in autosomal dominant polycystic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study [Phase 3]
A completed Phase 3 long-term follow-up study evaluating somatostatin in Autosomal Dominant Polycystic Kidney Disease (ADPKD).